These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 29306481)
41. Early and long-term outcomes after percutaneous coronary intervention of unprotected left main coronary disease with drug-eluting stents in patients with non-ST-elevation acute coronary syndrome. Zhao C; Wang X; Wu X; Cui L Can J Cardiol; 2011; 27(6):743-8. PubMed ID: 21875777 [TBL] [Abstract][Full Text] [Related]
42. Effect of Serum Fibrinogen, Total Stent Length, and Type of Acute Coronary Syndrome on 6-Month Major Adverse Cardiovascular Events and Bleeding After Percutaneous Coronary Intervention. Mahmud E; Ramsis M; Behnamfar O; Enright K; Huynh A; Kaushal K; Palakodeti S; Li S; Teh P; Lin F; Reeves R; Patel M; Ang L Am J Cardiol; 2016 May; 117(10):1575-1581. PubMed ID: 27040574 [TBL] [Abstract][Full Text] [Related]
43. Endothelial Dysfunction After ST-segment Elevation Myocardial Infarction and Long-term Outcome: A Study With Reactive Hyperemia Peripheral Artery Tonometry. Kandhai-Ragunath JJ; Doggen CJ; Jørstad HT; Doelman C; de Wagenaar B; IJzerman MJ; Peters RJ; von Birgelen C Rev Esp Cardiol (Engl Ed); 2016 Jul; 69(7):664-71. PubMed ID: 27068872 [TBL] [Abstract][Full Text] [Related]
44. Post-treatment platelet reactivity predicts long-term adverse events better than the response to clopidogrel in patients with non-ST-segment elevation acute coronary syndrome. de Miguel Castro A; Cuellas Ramón C; Diego Nieto A; Samaniego Lampón B; Alonso Rodríguez D; Fernández Vázquez F; Alonso Orcajo N; Carbonell de Blas R; Pascual Vicente C; Pérez de Prado A Rev Esp Cardiol; 2009 Feb; 62(2):126-35. PubMed ID: 19232185 [TBL] [Abstract][Full Text] [Related]
45. Single-Staged Compared With Multi-Staged PCI in Multivessel NSTEMI Patients: The SMILE Trial. Sardella G; Lucisano L; Garbo R; Pennacchi M; Cavallo E; Stio RE; Calcagno S; Ugo F; Boccuzzi G; Fedele F; Mancone M J Am Coll Cardiol; 2016 Jan; 67(3):264-72. PubMed ID: 26796390 [TBL] [Abstract][Full Text] [Related]
46. Outcome After Myocardial Infarction Treated With Resolute Integrity and Promus Element Stents: Insights From the DUTCH PEERS (TWENTE II) Randomized Trial. van Houwelingen KG; Lam MK; Löwik MM; Danse PW; Tjon Joe Gin RM; Jessurun GA; Anthonio RL; Sen H; Linssen GCM; IJzerman MJ; Doggen CJM; von Birgelen C Rev Esp Cardiol (Engl Ed); 2016 Dec; 69(12):1152-1159. PubMed ID: 27595181 [TBL] [Abstract][Full Text] [Related]
47. Complete or incomplete coronary revascularisation in patients with myocardial infarction and multivessel disease: a propensity score analysis from the "real-life" BleeMACS (Bleeding complications in a Multicenter registry of patients discharged with diagnosis of Acute Coronary Syndrome) registry. Quadri G; D'Ascenzo F; Moretti C; D'Amico M; Raposeiras-Roubín S; Abu-Assi E; Henriques JPS; Saucedo J; González-Juanatey JR; Wilton SB; Kikkert WJ; Nuñez-Gil I; Ariza-Sole A; Song X; Alexopoulos D; Liebetrau C; Kawaji T; Huczek Z; Nie SP; Fujii T; Correia L; Kawashiri MA; García-Acuña JM; Southern D; Alfonso E; Terol B; Garay A; Zhang D; Chen Y; Xanthopoulou I; Osman N; Möllmann H; Shiomi H; Omedè P; Montefusco A; Giordana F; Scarano S; Kowara M; Filipiak K; Wang X; Yan Y; Fan JY; Ikari Y; Nakahashi T; Sakata K; Yamagishi M; Kalpak O; Kedev S; Varbella F; Gaita F EuroIntervention; 2017 Jul; 13(4):407-414. PubMed ID: 28169217 [TBL] [Abstract][Full Text] [Related]
48. Comparison of 30-Day MACE between Immediate versus Staged Complete Revascularization in Acute Myocardial Infarction with Multivessel Disease, and the Effect of Coronary Lesion Complexity. Doğan C; Bayram Z; Çap M; Özkalaycı F; Unkun T; Erdoğan E; Uslu A; Acar RD; Guvendi B; Akbal ÖY; Karagöz A; Hakgor A; Karaduman A; Uysal S; Aykan A; Kaymaz C; Özdemir N Medicina (Kaunas); 2019 Feb; 55(2):. PubMed ID: 30781429 [No Abstract] [Full Text] [Related]
49. Complete or Culprit-Only Revascularization for Patients With Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Pairwise and Network Meta-Analysis of Randomized Trials. Elgendy IY; Mahmoud AN; Kumbhani DJ; Bhatt DL; Bavry AA JACC Cardiovasc Interv; 2017 Feb; 10(4):315-324. PubMed ID: 28231899 [TBL] [Abstract][Full Text] [Related]
50. Independent Predictors of Major Adverse Events following Coronary Stenting over 28 Months of Follow-Up. Golukhova EZ; Grigorian MV; Ryabinina MN; Bulaeva NI; Fortmann S; Serebruany VL Cardiology; 2015; 132(3):176-81. PubMed ID: 26277984 [TBL] [Abstract][Full Text] [Related]
51. Optimal Timing of Complete Revascularization in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis. Gaffar R; Habib B; Filion KB; Reynier P; Eisenberg MJ J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28396570 [TBL] [Abstract][Full Text] [Related]
52. Adverse events following percutaneous and surgical coronary revascularisation: Analysis of non-MACE outcomes in the Stent or Surgery (SoS) Trial. Roberts EB; Perry R; Booth J; Sigwart U; Stables RH Int J Cardiol; 2016 Jan; 202():7-12. PubMed ID: 26372883 [TBL] [Abstract][Full Text] [Related]
53. Usefulness of Post-coronary Dilation to Prevent Recurrent Myocardial Infarction in Patients Treated With Percutaneous Coronary Intervention for Acute Coronary Syndrome (from the BASE ACS Trial). Karjalainen PP; Niemelä M; Laine M; Airaksinen JK; Ylitalo A; Nammas W Am J Cardiol; 2017 Feb; 119(3):345-350. PubMed ID: 27887689 [TBL] [Abstract][Full Text] [Related]
54. Combination of Mean Platelet Volume and Neutrophil to Lymphocyte Ratio Predicts Long-Term Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention. Choi DH; Kobayashi Y; Nishi T; Kim HK; Ki YJ; Kim SS; Park KH; Song H; Fearon WF Angiology; 2019 Apr; 70(4):345-351. PubMed ID: 29631419 [TBL] [Abstract][Full Text] [Related]
55. [Effect of left ventricular ejection fraction on clinical long-term follow-up outcomes in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention]. Wang CH; Xie XJ; Fang Q; Zhang SY; Fang ZJ; Jiang XF; Xie HZ; Liu ZY; Shen ZJ Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):265-8. PubMed ID: 21418873 [TBL] [Abstract][Full Text] [Related]
56. High on-treatment platelet reactivity and outcome in elderly with non ST-segment elevation acute coronary syndrome - Insight from the GEPRESS study. De Rosa R; Palmerini T; De Servi S; Belmonte M; Crimi G; Cornara S; Calabrò P; Cattaneo M; Maffeo D; Toso A; Bartorelli A; Palmieri C; De Carlo M; Capodanno D; Genereux P; Angiolillo D; Piscione F; Galasso G Int J Cardiol; 2018 May; 259():20-25. PubMed ID: 29579602 [TBL] [Abstract][Full Text] [Related]
57. What is the optimal approach to a non- culprit stenosis after ST-elevation myocardial infarction - Conservative therapy or upfront revascularization? An updated meta-analysis of randomized trials. Anantha Narayanan M; Reddy YN; Sundaram V; Reddy YN; Baskaran J; Agnihotri K; Badheka A; Patel N; Deshmukh A Int J Cardiol; 2016 Aug; 216():18-24. PubMed ID: 27135152 [TBL] [Abstract][Full Text] [Related]
58. Association between serum 25(OH)D Samefors M; Scragg R; Länne T; Nyström FH; Östgren CJ Diabet Med; 2017 Mar; 34(3):372-379. PubMed ID: 27862247 [TBL] [Abstract][Full Text] [Related]
59. High-dose statin pretreatment decreases periprocedural myocardial infarction and cardiovascular events in patients undergoing elective percutaneous coronary intervention: a meta-analysis of twenty-four randomized controlled trials. Wang L; Peng P; Zhang O; Xu X; Yang S; Zhao Y; Zhou Y PLoS One; 2014; 9(12):e113352. PubMed ID: 25473831 [TBL] [Abstract][Full Text] [Related]
60. A comparison of multivessel and culprit vessel percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome patients with multivessel disease: a meta-analysis. Qiao Y; Li W; Mohamed S; Nie S; Du X; Zhang Y; Jia C; Wang X; Liu X; Ma C EuroIntervention; 2015 Sep; 11(5):525-32. PubMed ID: 26390516 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]